Association of plasminogen activator inhibitor-1 and vitamin D receptor expression with the risk of keloid disease in a Chinese population

Kaohsiung J Med Sci. 2017 Jan;33(1):24-29. doi: 10.1016/j.kjms.2016.10.013. Epub 2016 Dec 9.

Abstract

Keloid disease (KD) is a benign fibroproliferative scarring condition of unknown etiopathogenesis. Plasminogen activator inhibitor-1 (PAI-1) and vitamin D receptor (VDR) have been shown to play important roles in the progression of tissue fibrosis; therefore, both these genes are potential susceptibility genes for KD. We aimed to determine whether the gene expression levels of PAI-1 and VDR are altered in Chinese KD patients. We measured the expression of PAI and VDR in human peripheral blood lymphocytes in 236 patients with keloid and 219 age- and sex-matched healthy controls by quantitative real-time polymerase chain reaction. We found that PAI-1 expression in peripheral blood lymphocytes was significantly higher in patients with KD than in control individuals (p < 0.0001), while VDR expression was significantly lower in KD patients than in control individuals (p < 0.0001). High levels of PAI-1 and low levels of VDR expression were significantly associated with an increased risk for KD. PAI-1 and VDR might play important roles in keloid development. Gene expression levels of PAI-1 and VDR may, therefore, be used as potential markers for the prediction of keloid development after scarring.

Keywords: Chinese population; Keloid disease; Peripheral blood lymphocytes; Plasminogen activator inhibitor; Vitamin D receptor.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Asian People
  • Biomarkers / blood
  • Case-Control Studies
  • Child
  • Female
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Gene Expression Regulation
  • Genetic Predisposition to Disease*
  • Humans
  • Keloid / blood
  • Keloid / diagnosis
  • Keloid / ethnology
  • Keloid / genetics*
  • Leukocytes, Mononuclear / metabolism
  • Leukocytes, Mononuclear / pathology
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / blood
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Prognosis
  • Receptors, Calcitriol / blood
  • Receptors, Calcitriol / genetics*
  • Risk Factors

Substances

  • Biomarkers
  • Plasminogen Activator Inhibitor 1
  • Receptors, Calcitriol
  • SERPINE1 protein, human
  • VDR protein, human